Physician

Constance Stoehr, M.D.

According to 2025 Medicare claims, Constance Stoehr, M.D. (NPI: 1851579635) practices hematology/oncology in the Santa Maria-Santa Barbara, CA market, with the plurality of this provider's patient population coming from Santa Barbara, CA. This provider's primary affiliated billing organization is SANSUM CLINIC (NPI: 1932121514; TIN: 956419205) and primary practice location at 93105-4230. Stoehr is affiliated with the Aledade A3299 CA MSSP Enhanced (ACO ID: A3299), participating under the MSSP model.

Stoehr's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 437 traditional Medicare patients, billed 70,579 HCPCS/CPT codes, and received $997,409 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 468 prescription claims across 146 beneficiaries totaling $449,643 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 11 claims. Open Payments data shows 49 records totaling $3,766. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $39,283 and ending at $997,409. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $19,423 and ending at $449,643. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	183	479	$39,283
2016	160	485	$24,377
2017	152	382	$35,105
2018	201	702	$71,297
2019	276	825	$91,115
2020	189	480	$30,739
2021	221	512	$37,703
2022	200	443	$38,135
2023	286	1,830	$53,707
2024	437	70,579	$997,409

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	52	229	$19,423
2016	61	260	$232,897
2017	68	269	$416,148
2018	78	398	$734,111
2019	103	531	$1,347,020
2020	96	551	$1,120,248
2021	115	675	$1,338,438
2022	106	599	$881,806
2023	125	607	$425,986
2024	146	468	$449,643

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	87	$62,507
2016	N/R	11	$283
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	11	$3,420
2021	N/R	144	$55,165
2022	N/R	11	$1,651
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	67	67	$172
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	115	115	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	275	528	$103
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	56	78	$75
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	135	176	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	19	548	$10,855
Abiraterone Acetate	Abiraterone Acetate	12	360	$3,496
Anastrozole	Anastrozole	118	9,413	$2,021
Imatinib Mesylate	Imatinib Mesylate	12	360	$1,552
Letrozole	Letrozole	48	3,534	$1,074

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	49	$3,766	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Constance Stoehr, M.D.?

Tedicare shows public-source Medicare data for Constance Stoehr, M.D. (NPI 1851579635), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Constance Stoehr, M.D. have ACO affiliation data?

Constance Stoehr, M.D. is shown with ACO affiliation data for Aledade A3299 CA MSSP Enhanced (MSSP, ACO ID A3299).

What billing organization is linked to Constance Stoehr, M.D.?

Constance Stoehr, M.D. is linked to SANSUM CLINIC (billing NPI 1932121514) in the available physician profile data.

Does Constance Stoehr, M.D. have Open Payments data?

Constance Stoehr, M.D. has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.